Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Capital Employed (2021 - 2025)

Caribou Biosciences (CRBU) has disclosed Return on Capital Employed for 5 consecutive years, with 0.93% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 37.0% to 0.93% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.93% through Dec 2025, down 37.0% year-over-year, with the annual reading at 0.68% for FY2025, 19.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.93% at Caribou Biosciences, down from 0.88% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.16% in Q4 2021, with the low at 0.93% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 0.42%, with a median of 0.34% recorded in 2023.
  • The sharpest move saw Return on Capital Employed grew 2bps in 2023, then tumbled -38bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.16% in 2021, then tumbled by -86bps to 0.3% in 2022, then increased by 6bps to 0.28% in 2023, then tumbled by -101bps to 0.56% in 2024, then crashed by -66bps to 0.93% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.93%, 0.88%, and 0.77% for Q4 2025, Q3 2025, and Q2 2025 respectively.